These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12536547)

  • 1. [Changes of serum soluble tumor necrosis factor receptor I in patients with rheumatic fever].
    Chen CY; Yang ZC; Lian NW
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):571-2. PubMed ID: 12536547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
    Kawaguchi H; Ina Y; Ito S; Sato S; Sugiura Y; Tomita H; Ogisu N; Takada K; Yamamoto M; Morishita M; Yoshikawa K
    Kekkaku; 1996 Mar; 71(3):259-65. PubMed ID: 8901228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation and clinical significance of serum soluble tumor necrosis factor receptors in patients with acute leukemia].
    Lin M; Meng X
    Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):245-8. PubMed ID: 11601213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum levels of soluble tumor necrosis factor receptors as markers for disease progression of human immunodeficiency virus infection].
    Hattori M; Tateyama M; Oishi T; Miyasaka S; Fukutake K
    Rinsho Byori; 1997 Nov; 45(11):1085-90. PubMed ID: 9396350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
    Serwin AB; Wasowicz W; Chodynicka B
    Nutrition; 2006 Sep; 22(9):860-4. PubMed ID: 16829029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
    Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
    Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of soluble tumor necrosis factor-p55 levels in the serum and ascitic fluid of patients with hepatocellular carcinoma.
    Gao L; Bai L; Nan QZ; Yang XS; Chen K; Wen HP; Lai ZS; Bo L; Zhang YL; Zhang ZS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):641-3. PubMed ID: 12376300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
    Sikora JP; Kuzański W; Andrzejewska E
    Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.
    Godfried MH; van der Poll T; Jansen J; Romijin JA; Schattenkerk JK; Endert E; van Deventer SJ; Sauerwein HP
    AIDS; 1993 Jan; 7(1):33-6. PubMed ID: 8382926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study.
    Burger RA; Darcy KM; DiSaia PJ; Monk BJ; Grosen EA; Gatanaga T; Granger GA; Wang J; Tian C; Hanjani P; Cohn DE
    Cancer; 2004 Jul; 101(1):106-15. PubMed ID: 15221995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of serum soluble tumor necrosis factor receptor-I in patients with head and neck neoplasm].
    Dong W; Xu J; Qiao Z; Wang N; Yu R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):468-70. PubMed ID: 12761967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human soluble tumor necrosis factor receptor I (sTNF-RI) and interleukin-I receptor antagonist (IL-I Ra) in different stages of acute rheumatic fever.
    Kütükçüler N; Karaca NE; Sözeri BY; Koturoğlu G; Kurugöl Z; Ozyürek RA; Aksu G
    Anadolu Kardiyol Derg; 2008 Apr; 8(2):139-42. PubMed ID: 18400635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia.
    Coelho FM; Reis HJ; Nicolato R; Romano-Silva MA; Teixeira MM; Bauer ME; Teixeira AL
    Neuroimmunomodulation; 2008; 15(2):140-4. PubMed ID: 18679053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients.
    Vilarrasa N; Vendrell J; Sánchez-Santos R; Broch M; Megia A; Masdevall C; Gomez N; Soler J; Pujol J; Bettónica C; Aranda H; Gómez JM
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):679-86. PubMed ID: 17608757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haptoglobin in rheumatic fever.
    Anil K; Praveen K; Sadhna ; Gupta PK
    Mater Med Pol; 1995; 27(3):108-10. PubMed ID: 8935147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria.
    Matsiegui PB; Missinou MA; Issifou S; Necek M; Mavoungou E
    Eur Cytokine Netw; 2007 Dec; 18(4):201-5. PubMed ID: 17964975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.